BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 34487251)

  • 1. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.
    Zahid N; Martins RS; Zahid W; Khalid W; Azam I; Bhamani SS; Asad N; Ahmad K; Jabbar AA; Shamim MS; Khan RJ; Javed G; Bari E; Enam SA
    J Patient Rep Outcomes; 2021 Sep; 5(1):79. PubMed ID: 34487251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of health-related quality of life in Lithuanian brain tumor patients using the EORTC brain cancer module.
    Bunevičius A; Tamašauskas Š; Tamašauskas A; Deltuva V
    Medicina (Kaunas); 2012; 48(11):588-94. PubMed ID: 23455894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Chinese version of EORTC QLQ-BN20 for patients with brain cancer.
    Zhang K; Tian J; He Z; Sun W; Pekbay B; Lin Y; Wu D; Zhang J; Chen P; Guo H; Wan Y; Wang M; Yang S; Zheng J; Zhang L
    Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12832. PubMed ID: 29461664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of Questionnaires for Quality of Life of Patients with Malignant Tumors of the Central Nervous System into Neurosurgical Practice in the Republic of Kazakhstan.
    Akshulakov S; Aldiyarova N; Ryskeldiyev N; Akhmetzhanova Z; Gaitova K; Auezova R; Doskaliyev A; Kerimbayev T
    Asian Pac J Cancer Prev; 2016; 17(2):873-6. PubMed ID: 26925695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
    Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.
    Chiu L; Chiu N; Zeng L; Zhang L; Popovic M; Chow R; Lam H; Poon M; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):831-7. PubMed ID: 23252363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran.
    Khoshnevisan A; Yekaninejad MS; Ardakani SK; Pakpour AH; Mardani A; Aaronson NK
    Health Qual Life Outcomes; 2012 May; 10():54. PubMed ID: 22607028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
    Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
    Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review.
    Leung A; Lien K; Zeng L; Nguyen J; Caissie A; Culleton S; Holden L; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):693-700. PubMed ID: 22098285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the EORTC QLQ-BN20 and the FACT-Br quality of life questionnaires for patients with primary brain cancers: a literature review.
    Chow R; Lao N; Popovic M; Chow E; Cella D; Beaumont J; Lam H; Pulenzas N; Bedard G; Wong E; DeAngelis C; Bottomley A
    Support Care Cancer; 2014 Sep; 22(9):2593-8. PubMed ID: 25015058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
    Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-cultural application of the Korean version of the EORTC QLQ-ELD14 questionnaire for elderly patients with cancer.
    Goo AJ; Shin DW; Yang HK; Park JH; Kim SY; Shin JY; Kim YA; Kim C; Hong NS; Min YJ; Park K
    J Geriatr Oncol; 2017 Jul; 8(4):271-276. PubMed ID: 28377101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resilience and quality of life (QoL) of head and neck cancer and brain tumour survivors in Pakistan: an analytical cross-sectional study protocol.
    Zahid N; Khalid W; Ahmad K; Bhamani SS; Azam I; Asad N; Jabbar AA; Khan M; Enam A
    BMJ Open; 2019 Sep; 9(9):e029084. PubMed ID: 31542743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer.
    Tomaszewski KA; Püsküllüoğlu M; Biesiada K; Bochenek J; Nieckula J; Krzemieniecki K
    J Psychosoc Oncol; 2013; 31(2):191-203. PubMed ID: 23514254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.